Co-Founder & CEO, Mesh Bio
Andrew Wu is the Co-Founder and CEO of Mesh Bio, a digital health startup focused providing analytics solutions based on computational biology and AI, for chronic disease diagnosis and management. He was previously Chief Operating Officer of Clearbridge Biomedics (now known as Biolidics) where he developed innovative cancer diagnostics technology in the field of liquid biopsy. He was also Chief Product Officer of Clearbridge Health. Both companies are now listed on SGX Catalist.
Andrew holds a Bachelors and PhD in Biochemical Engineering from University College London.